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Abstract 16 
Background: Multi-tracer PET/SPECT imaging enables different modality tracers to be present 17 
simultaneously, allowing multiple physiological processes to be imaged in the same subject, 18 
within a short time-frame. Fluorine-18 and technetium-99m, two commonly used PET and 19 
SPECT radionuclides respectively, possess different emission profiles, offering the potential 20 
for imaging one in the presence of the other. However, the impact of the presence of each 21 
radionuclide on scanning the other could be significant and lead to confounding results. Here 22 
we use combinations of 18F and 99mTc to explore the challenges posed by dual tracer 23 
PET/SPECT imaging, and investigate potential practical ways to overcome them. 24 
Methods: Mixed-radionuclide 18F/99mTc phantom PET and SPECT imaging experiments were 25 
carried out to determine the crossover effects of each radionuclide on the scans using Mediso 26 
nanoScan PET/CT and SPECT/CT small animal scanners. 27 
Results: PET scan image quality and quantification were adversely affected by 99mTc activities 28 
higher than 100 MBq due to a high singles rate increasing dead-time of the detectors. Below 29 
100 MBq 99mTc, PET scanner quantification accuracy was preserved. SPECT scan image 30 
quality and quantification were adversely affected by the presence of 18F due to Compton 31 
scattering of 511 keV photons leading to over-estimation of 99mTc activity and increased noise. 32 
However, 99mTc:18F activity ratios of > 70:1 were found to mitigate this effect completely on 33 
the SPECT. A method for correcting for Compton scatter was also explored. 34 
Conclusion: Suitable combinations of injection sequence and imaging sequence can be devised 35 
to meet specific experimental multi-tracer imaging needs, with only minor or insignificant 36 
effects of each radionuclide on the scan of the other. 37 
 38 
 39 
Introduction 40 
Individually, PET and SPECT tracers allow us to probe the underlying molecular 41 
characteristics of physiological processes, one mechanism at a time. The ability to image one 42 
tracer in the presence of another – dual radionuclide PET/SPECT imaging – enables different 43 
modality tracers to be present simultaneously, thus allowing multiple processes to be imaged 44 
in the same subject, within a much shorter period of time (removing the need to wait for tracer 45 
decay). For example, radionuclides fluorine-18 (PET) and technetium-99m (SPECT) each 46 
possess different emission profiles and, in theory, can be imaged in the presence of the other, 47 
but the impact of each on scanning of the other (i.e. the SPECT and PET scans respectively), 48 
could be significant and lead to confounding results. 49 
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Acquiring a PET image in the presence of a SPECT radionuclide may introduce additional 50 
dead-time (the time after each photon is detected by the scanner during which the system is not 51 
able to record another event). Photons emitted from decaying 99mTc nuclei are not coincident, 52 
and their energy of 140 keV is much lower than the 511 keV PET scanner energy window, so 53 
do not contribute to the image data acquired. However, they do interact with the PET detectors, 54 
and at high enough flux, can potentially prevent true coincidence events from the positron 55 
emitter being recorded. One study in mice showed PET signal loss of 12% due to increased 56 
dead-time when 99mTc was present in an almost 10-fold higher activity compared to 18F (1). It 57 
is worth noting that this phenomenon is not specific to mixed radionuclide effects, and dead-58 
time is generally recognised as a performance-limiting factor at high concentrations of PET 59 
tracers (2).  60 
Performing a SPECT scan in the presence of a PET radionuclide can also be problematic. If 61 
18F is present during a 99mTc SPECT scan, a proportion of the photons from 18F positron 62 
annihilation will enter the SPECT 99mTc energy window (140.5 keV, ±10% i.e. 20% width) 63 
due to Compton scattering – the scattering of a photon by a charged particle, resulting in a 64 
decrease in energy and change in trajectory of the photon. Previous studies have shown that 65 
this down-scatter can generate significant noise and artefacts in the SPECT image (1). A 66 
clinical study showed that the simultaneous use of 99mTc-sestamibi and [18F]FDG (with a 67 
99mTc:18F ratio of 3.2:1) resulted in a <6 % increase in the apparent 99mTc count rate due to 68 
down-scatter from 18F (3). This overestimation can be corrected for on clinical scanners by the 69 
use of auxiliary energy windows; such methods use the signal in parts of the spectrum outside 70 
the photopeak window to estimate an amount of signal to subtract from the imaging window 71 
to correct for scatter (4, 5). However, these methods may be difficult to implement in a 72 
preclinical setting due to the low volume of the scatter medium (mice, rats etc.) and hardware 73 
and software constraints. 74 
Here, we explore some of the challenges posed by dual tracer PET/SPECT preclinical imaging 75 
using radionuclides 18F and 99mTc as examples, and investigate potential practical ways to 76 
overcome these obstacles by appropriate experimental design. Mixed-radionuclide 18F/99mTc 77 
phantom experiments were carried out to determine the crossover effects of each radionuclide 78 
on the scans, and ultimately, to help design the optimal protocol for in vivo dual radionuclide 79 
preclinical imaging using 18F and 99mTc. 80 
 81 
 82 
Methods 83 
PET scanner phantoms 84 
Plastic syringes (5 mL) were filled with either 18F only (5 MBq), 99mTc only (5 MBq) or 85 
mixtures of 18F (5 MBq) and increasing amounts of 99mTc (5, 50, 100, 150, 200, 250, 350 MBq). 86 
Activities of 5 MBq 18F and < 200 MBq 99mTc reflect routine protocols avoiding count-rate 87 
limitations of each modality separately. Volumes were made up to 3 mL by addition of water. 88 
Radioactivity in each syringe was measured using a dose calibrator (Capintec, Ramsey, NJ, 89 
USA), calibrated to the national standard. First the syringe was filled with 18F only and the 90 
activity measured. Then the required activity of 99mTc was prepared in a microcentrifuge tube, 91 
measured in the dose calibrator, and transferred to the syringe. Residual 99mTc activity in the 92 
needle and microcentrifuge tube was subtracted from the measured activity. Syringes were 93 
inverted several times for uniform distribution of radioactivity. Each syringe was placed in the 94 
pre-calibrated nanoPET/CT (Mediso, Budapest, Hungary) and a 15 min PET scan was 95 
acquired. The PET system sensitivity was 4.67% for a 350-650 keV energy window and 4 ns 96 
coincidence window (2). Subsequently, a CT scan was obtained for attenuation correction with 97 
a 55 kVp X-ray source, 600 ms exposure time in 180 projections over approximately 6 min. 98 
PET images were reconstructed in Nucline v0.21 using Tera-Tomo 3D reconstruction with 4 99 
Commented [JB1]: CT parameters for the PET 
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iterations, 6 subsets, 1-3 coincidence mode, voxel sized 0.4 mm (isotropic), energy window 100 
400-600 keV with attenuation and scatter correction. Images were analysed in VivoQuant 101 
v.3.5, patch 2 software (Invicro LLC., Boston, USA). The activity was determined within a 102 
cylindrical ROI slightly larger than the syringe. The same cylindrical ROI was used for each 103 
scan and translated or rotated to accommodate variations in the placement of each syringe. The 104 
resulting activity from the PET/CT scan was compared to the decay-corrected activity 105 
measured in the dose calibrator. Quantitative assessment of image quality was assessed by 106 
calculating the coefficient of variation for each image: a small spherical ROI was drawn over 107 
the images and the standard deviation within the ROI was divided by the mean within that ROI 108 
(Supplementary figure 1).  109 
 110 
  111 
SPECT scanner phantoms 112 
Plastic microcentrifuge tubes (1.5 mL) were filled with either 99mTc only (1 MBq), 18F only (1 113 
MBq), or mixtures of 99mTc (1, 10, 30, 50, 70 MBq) and 18F (1 MBq) to achieve 99mTc:18F ratios 114 
ranging from 1:1 to 70:1. Volumes were made up to 1 mL by addition of water. Radioactivity 115 
in each tube was measured using a dose calibrator (Capintec, Ramsey, NJ, USA), calibrated to 116 
the national standard. First the tube was filled with 18F only and the activity measured. Then 117 
the required activity of 99mTc was prepared in a second microcentrifuge tube, measured in the 118 
dose calibrator, and transferred to the first tube. Residual 99mTc activity in the needle and 119 
second tube was subtracted from the measured activity. Tubes were inverted several times and 120 
vortexed for uniform distribution of radioactivity. Each tube was placed in the pre-calibrated 121 
nanoSPECT/CT Silver Upgrade (Mediso Ltd., Budapest, Hungary) and imaged with 122 
acquisition time 15 min, frame time of 35 s using a 4-head scanner with 4 × 9 (1 mm) pinhole 123 
collimators in helical scanning mode, and CT images with a 55 kVp X-ray source, 1000 ms 124 
exposure time in 180 projections over approximately 9 min. Images were reconstructed in a 125 
256 × 256 matrix, voxel size 0.3 mm (isotropic) using HiSPECT (ScivisGmbH) a 126 
reconstruction software package, and images were fused using proprietary VivoQuant v.3.5, 127 
patch 2 software (InVicro LLC., Boston, USA). The resulting activity from the SPECT/CT 128 
scan was compared to the decay-corrected activity measured in the dose calibrator. 129 
 130 
 131 
Compton scatter data correction 132 
A method to correct for the effects of 511 keV scattered photons on SPECT image 133 
quantification and quality was explored. A set of phantom experiments was performed on the 134 
nanoSPECT/CT as proof-of-concept. To obtain an 18F scatter map, a microcentrifuge tube 135 
containing 18F only (2 MBq, 1 mL) was placed in a 50 mL Falcon tube of water (to mimic 136 
preclinical scatter conditions) and a 15 min SPECT scan was acquired, followed by a CT scan. 137 
Next, a tube containing a mixture of 99mTc (50 MBq) and 18F (2 MBq) was placed in a 50 mL 138 
Falcon tube on the scanner and a 15 min scan was acquired, followed by a CT scan. Finally, a 139 
tube containing 99mTc only (50 MBq) was placed on the scanner and a 15 min scan was 140 
acquired. The scatter correction was applied by subtracting the 18F-only SPECT scatter map 141 
from the mixed-radionuclide SPECT scan, according to the programming code (Python 3) in 142 
Supplementary figure 2a. Automatic scatter correction was applied by scaling the voxel values 143 
in both the 18F-only scan and the mixed-radionuclide scan using their "COUNTS Real World 144 
Value Slope" as determined by the SPECT scanner calibration saved in the original dicom files. 145 
This allowed a matrix subtraction to be performed where each voxel value corresponded 146 
directly with real world counts, as measured by the SPECT. The images were then converted 147 
back using the Value Slope for the original mixed-radionuclide image (Supplementary figure 148 
2b). Both the original and scatter-corrected images were analysed in VivoQuant v.3.5, patch 2 149 
Commented [JB2]: Corrected kVp 
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software (Invicro LLC., Boston, USA). The activity in each image was determined using the 150 
same ROI, within a region slightly larger than the microcentrifuge tube. The activity quantified 151 
in both images was compared to the decay-corrected activity measured in the dose calibrator. 152 
 153 
It is important to note that the radioactivity quantities used in these experiments reflect the 154 
doses appropriate for our scanner system specifications; tested doses may need to be adjusted 155 
for other systems. 156 
 157 
 158 
Results 159 
 160 
Effect of 99mTc on PET scans 161 
The effect of the presence of SPECT radionuclide 99mTc on 18F PET scans was assessed by the 162 
use of phantoms. The PET scanner was calibrated prior to the start of the study following 163 
manufacturer procedures; 18F-only phantoms measured in the dose calibrator and PET scanner 164 
showed good agreement (within 2 %).  165 
In the presence of up to 100 MBq 99mTc, 5 MBq 18F was accurately quantified by the PET 166 
scanner: an over-estimation of < 5% activity was observed in the presence of 50 and 100 MBq 167 
99mTc (Figure 1). At higher activities of 99mTc, PET scanner quantification became less accurate 168 
and consistently under-estimated the amount of 18F present. At 150 MBq of 99mTc, 18F 169 
quantification was underestimated by < 10% and became progressively worse with increasing 170 
amounts of 99mTc: at 350 MBq the scanner was underestimating activity of 18F by > 80% 171 
(Figure 1). The live acquisition energy spectrum (Figure 2,  Supplementary figure 3) showed 172 
that at these higher activities of 99mTc, photons at 140 keV (attributable to 99mTc decay) 173 
overwhelmed the detection of 511 keV photons originating from 18F decay suggesting that the 174 
dead-time correction could not cope with the increased singles rate. Note that the true counts 175 
decrease considerably when adding 99mTc to 18F (Supplementary Table 1 -2). However, activity 176 
quantification showed low errors up to 100 MBq added 99mTc (Figure 1) due to the intrinsic 177 
dead-time correction of the scanner. Note also that both 99mTc only and water have similar 178 
numbers of true counts which originate from the intrinsic radiation of the LYSO:Ce crystals. 179 
The effect of 99mTc on PET image quality was examined (qualitatively) by observing image 180 
noise present with increasing 99mTc activity in the field-of-view. PET image quality was 181 
maintained in the presence of 5 MBq 99mTc when compared to its 18F-only control (Figure 3). 182 
Addition of 50 MBq 99mTc caused image quality (in terms of signal-to-noise) to deteriorate 183 
noticeably, with images becoming more diffuse and lacking in definition. Image quality 184 
became progressively worse with increasing amounts of 99mTc (Figure 3). These qualitative 185 
observations were supported by quantitative analysis of the images: the coefficient of variation 186 
for each image increased with increasing amounts of 99mTc present (Figure 4). 187 
Effect of 18F on SPECT scans 188 
The effect of the presence of PET radionuclide 18F on 99mTc SPECT scans was assessed by the 189 
use of phantoms. The SPECT scanner calibration was checked prior to the start of the study: 190 
99mTc-only phantoms measured in the dose calibrator and SPECT scanner showed good 191 
agreement (within 5 %).  192 
At equivalent activities of 99mTc and 18F (1:1), quantification of 99mTc was poor, with the 193 
scanner overestimating 99mTc activity by > 150% (1 MBq vs. 2.75 MBq) (Figure 5). A 10-fold 194 
increase in the activity of 99mTc relative to 18F dramatically improved scanner quantification 195 
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accuracy, reducing 99mTc activity overestimation to 10% (Figure 5). Further increases in the 196 
quantity of 99mTc incrementally improved scanner quantification accuracy in the presence of 1 197 
MBq 18F. The adverse effects of 18F on scanner quantification accuracy were mitigated 198 
completely when 99mTc was in 70-fold excess compared to 18F (Figure 5). SPECT image quality 199 
was also affected by the presence of 18F, with high levels of noise observed at 99mTc:18F ratios 200 
of 1:1 and 10:1 (Figure 6). At ratios of 30:1 and above, noise levels observed qualitatively in 201 
the images were significantly reduced and images became sharper (Figure 6). The acquisition 202 
energy spectrum of an 18F-only phantom on the SPECT scanner showed detection of a range 203 
of photon energies, including some in the 140 ±10% (20% width) keV 99mTc energy window 204 
(Figure 7). 205 
Compton scatter data correction 206 
The SPECT scanner calibration was checked prior to the start of the study: 99mTc-only 207 
phantoms measured in the dose calibrator and SPECT scanner showed good agreement (within 208 
1 %): a 99mTc-only sample measured 50.8 MBq and 51.0 MBq in the dose calibrator and the 209 
SPECT scanner, respectively. The mixed-radionuclide sample containing 18F (2 MBq) plus 210 
99mTc (50.7 MBq, measured by dose calibrator) was quantified as 55.84 MBq on the SPECT 211 
scanner in the 140 ±10% keV window, an over-estimate of 10 % resulting from the contribution 212 
of Compton-scattered 511 keV photons to the 140 keV window. Upon subtraction of the 18F-213 
only phantom counts from the mixed 18F+99mTc counts, the resulting “scatter-corrected” data 214 
were quantified at 51.89 MBq, an over-estimation of only 2%. The coefficient of variation for 215 
the original image and scatter-corrected image was 0.098 and 0.102, respectively. The resulting 216 
image was visibly similar to the 99mTc-only control image, showing a substantial reduction in 217 
noise and comparable activity compared to the mixed-radionuclide image (Figure 8). This 218 
could be implemented in practice as data correction: initially a SPECT scan of the 18F present 219 
is acquired before injection of 99mTc, to establish the 18F down-scatter contribution; following 220 
injection of 99mTc and acquisition of the SPECT scan, the 18F down-scatter component is 221 
subtracted to provide an accurate 99mTc uptake distribution. 222 
 223 
Discussion 224 
 225 
Our specific motivation for this work originated from the need to compare directly two PET 226 
tracers for the same biological target, both labelled with 18F, to understand subtle differences 227 
in behaviour between the two tracers in vivo. Since the two tracers were labelled with the same 228 
PET radionuclide, and hence had identical physical emission profiles, they could not be 229 
compared simultaneously in the same animal. A consecutive imaging protocol (administration 230 
and PET imaging of the first tracer, followed by administration and PET imaging of the second 231 
tracer in the same animal) was possible, in theory. However, the need to allow the first tracer 232 
to decay sufficiently to prevent residual activity interfering with the second scan, combined 233 
with limits on animal exposure to anaesthesia and recovery time (our specific animal licence 234 
requires a minimum of 3 h between mouse recovery and being re-anaesthetised) means the 235 
imposed delay between tracer administration could lead to significant physiological changes 236 
(effects of anaesthesia, metabolism, tumour size etc.) in the animal between the two scans. 237 
Similarly, evaluating each tracer in a different animal introduces inherent variability between 238 
mice, thus no longer maintaining a controlled environment for accurate tracer comparison. 239 
Our solution was to adopt a paired-control approach, using a single SPECT (99mTc) tracer (for 240 
the same biological target) in conjunction with each PET tracer, where each tracer can be 241 
imaged in the presence of the other because 18F and 99mTc possess different emission profiles. 242 
Thus the need to understand the impact of each radionuclide on the scanning of the other 243 
presented itself, and mixed-radionuclide 18F/99mTc phantom experiments were carried out to 244 
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determine the crossover effects of each radionuclide on the scans. Of course, dual radionuclide 245 
PET/SPECT imaging is not only relevant to our niche example; it is of value more generally, 246 
to enable evaluation of different, but related, biological systems at (almost) the same time using 247 
different tracers labelled with different radionuclides. 248 
Firstly we examined the effect of 99mTc on 18F PET scans. Dead-time effects are observed on 249 
the PET scanner when there is too much of any radionuclide. A previous Noise Equivalent 250 
Counting (NEC) study performed on our PET scanner showed count-rate peaks at 430 kcps at 251 
36 MBq and 130 kcps at 27 MBq for 18F in mouse and rat phantoms, respectively (2). The 252 
injected activity for a mouse in our PET scanner is typically 2-10 MBq; 5 MBq 18F was used 253 
in this phantom experiment, which is well below the NEC peaks, and therefore quantification 254 
is not affected by dead-time when this quantity of 18F alone is used. However, when combined 255 
with 99mTc, we must assess the contribution of 99mTc photons emitted to scanner dead-time, and 256 
hence the effects on PET image quality and quantification. We see that when combined with 257 
lower amounts of 99mTc (<100 MBq), 18F quantification is unaffected, but 140 keV photon 258 
contribution from higher amounts of 99mTc (>150 MBq) prevents coincident 511 keV PET 259 
photons being recorded, causing the scanner to significantly underestimate 18F activity. In 260 
practice, a typical 99mTc SPECT scan requires only 10-40 MBq injection. These results enable 261 
us to assess the feasibility of a hypothetical imaging protocol as follows: (i) administration of 262 
SPECT tracer (99mTc, 40 MBq) (ii) SPECT image acquisition (1 h) (iii) administration of PET 263 
tracer (18F, 5 MBq) (iv) PET image acquisition (1 h), in the presence of 99mTc. Our phantom 264 
studies show that at these levels of activity, 18F PET quantification is not affected by the 265 
presence of 99mTc. However, even at levels of 99mTc where quantification accuracy is 266 
maintained, PET image quality does appear to be compromised. In the presence of 50 MBq 267 
99mTc, images becomes a little more diffuse with reduced definition. While this slight decrease 268 
in image quality is unlikely to be problematic for the majority of imaging scenarios, it could 269 
make identification and visualisation of very small biological structures (e.g. tumour 270 
metastases) more difficult.  271 
Next we examined the effect of 18F on 99mTc SPECT scans. In the presence of 18F, 99mTc SPECT 272 
image quantification and quality were affected by Compton scatter, leading to an over-273 
estimation of 99mTc and increase in noise. However, when 99mTc activity was 70-fold higher 274 
than 18F this over-estimation could be mitigated completely and image quality preserved.  275 
In practice, a good 1 h dynamic PET scan can be achieved with 3 MBq 18F alone and, taking 276 
into account decay (t1/2 = 109.8 min), no more than 2 MBq of 
18F tracer would be residual in 277 
the animal after the 1 h scan. Our results enable assessment of the feasibility of an alternative 278 
hypothetical imaging protocol, as follows: (i) administration of PET tracer (18F, 3 MBq) (ii) 279 
PET image acquisition (1 h) (iii) administration of SPECT tracer (99mTc, > 140 MBq, to 280 
maintain 70:1 99mTc:18F ratio) (iv) SPECT image acquisition (1 h) in the presence of 18F. Our 281 
phantom studies show that at these radionuclide activity ratios, 99mTc SPECT image 282 
quantification and quality is not affected by the presence of 18F. However, although we can 283 
control this radionuclide activity ratio at the time of SPECT tracer injection, we cannot know 284 
if this 70:1 ratio is maintained in vivo – the biodistribution of both PET and SPECT tracers 285 
would need to be similar for this to be true. This, plus the need for otherwise unnecessarily 286 
high levels of radioactivity, makes this protocol an inferior option. 287 
From a biological perspective, it would be preferable to co-administer both tracers at the same 288 
time, but based on our findings, there is no combination of imaging sequence and tracer 289 
quantity (without waiting several hours for radionuclide decay) that would allow the two 290 
radionuclides to be injected simultaneously and each scanned in the presence of the other, 291 
without having a major effect on image quality and quantification. Furthermore, images of each 292 
tracer at the same time after injection could not be obtained with simultaneous injection. 293 
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We also explored simple computational methods for correcting for the effects of Compton 294 
scatter on the SPECT scanner. One approach involves using the 18F-only PET scan to identify 295 
sources of 18F, and then subtracting this from the mixed-radionuclide SPECT scan. This process 296 
becomes quite complex because we are attempting to combine data collected from two different 297 
and essentially unrelated pieces of equipment; differences between the PET and SPECT 298 
scanners must be accounted for and this requires additional calibration steps to be done for 299 
each set of measurements obtained on the scanners. An additional complication of this method 300 
is the need to maintain animal position between the two scanners so that images can be 301 
accurately co-registered. Even with the most careful transfer between scanners (the animal bed 302 
is compatible with both scanners and could be transferred without removing the mouse), a 303 
registration step would be required using the CT scans of the mice to obtain a “best case” match 304 
for the scatter map. While it would be possible to produce a warp field for the mouse shift in 305 
position, this quickly becomes an overly-complex solution. A more practical approach might 306 
therefore be achieved using the SPECT scanner directly to obtain an 18F scatter map, prior to 307 
injection of 99mTc. This method would involve incorporating an additional SPECT scan into 308 
the scanning protocol and makes the assumption that scatter present in the 18F-only scatter map 309 
is comparable to that obtained when the SPECT tracer is also present (i.e. no change in 310 
biodistribution between SPECT scans). The scatter map must also be corrected for radionuclide 311 
decay between scans. Our proof-of-concept phantom experiment demonstrated that this scatter-312 
correction method could be used easily and successfully to remove noise caused by Compton 313 
scattering of 18F photons. The proposed preclinical imaging protocol would then be as follows: 314 
(i) administration of PET tracer (18F) (ii) PET image acquisition (iii) SPECT image acquisition 315 
(to obtain 18F scatter map) (iv) administration of SPECT tracer (99mTc) (v) SPECT image 316 
acquisition (in the presence of 18F) (vi) scatter map image subtraction. This approach builds 317 
the scatter map acquisition into the scanning protocol, and would therefore be applicable to any 318 
PET/SPECT radionuclide combination, any radionuclide activity, and any scanner model, 319 
without requiring calibration for each experiment, making this method an attractive option for 320 
dual radionuclide PET/SPECT imaging. 321 
The ability to obtain accurate parallel scans with PET and SPECT tracers would allow the 322 
limits of molecular imaging to be extended and would be useful for comparison of different 323 
radiotracers or to image multiple related molecular processes simultaneously to obtain a deeper 324 
understanding of interlinked processes. Examples could include temporospatial mapping of 325 
anti-cancer drug delivery (e.g. via liposomal formulation) and response in relation to the 326 
disease site (6), and in advanced cell-based therapies where the trafficking of cells to disease 327 
sites has to be quantified alongside mapping of the disease and response to therapy. Similarly, 328 
SPECT imaging of the biodistribution of therapeutic radionuclides that emit both imageable 329 
gamma photons (e.g. 177Lu, 67Cu, 188Re) could be performed alongside PET imaging (e.g. with 330 
[18F]FDG or other tracer) of metabolic response to therapy. It would also enable imaging of 331 
multiple molecular characteristics of disease in an animal to obtain metabolic and gene 332 
expression profiles or characterise diseases such as cancer where heterogeneity is to be 333 
expected. 334 
 335 
Conclusion 336 
Sequential PET and SPECT data acquisition whilst both positron- and gamma-emitters are 337 
present is feasible under certain conditions without substantial influence on image 338 
quantification accuracy. Suitable combinations of injection sequence and imaging sequence 339 
can be devised to match the biological requirements of a particular experiment, using existing 340 
commercial small animal PET and SPECT scanners, with only minor or insignificant effects 341 
of each radionuclide on the scan of the other. However simultaneous tracer injection is not 342 
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feasible under any combination of imaging sequence and tracer quantity, and does not allow 343 
images of each tracer to be obtained at the same time after injection. 344 
 345 
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Figure captions 397 
Figure 1. Effect of different amounts of 99mTc on the accuracy of PET scanner quantification 398 
of 5 MBq 18F. The effect on scanner quantification was assessed by comparing the amount of 399 
18F measured by the dose calibrator to that measured by the PET scanner; n=3, mean ± SD. 400 
Grey box inset provides zoom of 0-150 MBq region. 401 
 402 
Figure 2. Live acquisition energy spectrum obtained during a PET scan of a mixed 403 
radionuclide phantom containing 5 MBq 18F and 250 MBq 99mTc. The yellow peak at 140 keV 404 
corresponds to the energy of 99mTc γ photons, which reduces detection of 18F coincident 405 
photons at 511 keV. 406 
 407 
Figure 3. PET-CT MIPs of mixed-radionuclide 18F + 99mTc phantoms. Each syringe contains 408 
18F (5 MBq) mixed with increasing amounts of 99mTc (0-350 MBq). An 18F only (5 MBq) 409 
control is included for comparison. 410 
 411 
Figure 4. Effect of increasing amounts of 99mTc on the PET image quality of 5 MBq 18F, 412 
quantified by calculating the coefficient of variation within an ROI for each image (SD/mean); 413 
n=3. 414 
 415 
Figure 5. Effect of 18F (1 MBq) on the accuracy of SPECT scanner quantification of increasing 416 
amounts of 99mTc. The effect on scanner quantification was assessed by comparing the amount 417 
of 99mTc measured by the dose calibrator to that measured by the SPECT scanner. 418 
 419 
Figure 6. SPECT-CT MIPs of 99mTc only and mixed-radionuclide 99mTc + 18F phantoms. Each 420 
tube contained either 99mTc only (1, 10, 30, 50, 70 MBq) or 99mTc (1, 10, 30, 50, 70 MBq) 421 
mixed with 18F (1 MBq). All images scaled to the same threshold and intensity. 422 
 423 
Figure 7. Live acquisition energy spectrum obtained during a SPECT scan of an 18F-only 424 
phantom (1 MBq). A range of energies is evident, including energies in the 140.5 keV ±10% 425 
(i.e. 20% width) 99mTc energy window (red). 426 
 427 
Figure 8. Proof-of-concept for SPECT scatter data correction method. The 18F-only scatter 428 
map image was subtracted from the 99mTc + 18F mixed-radionuclide image to achieve the final 429 
scatter-corrected image. The 99mTc-only image is included for comparison. 430 
